Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

HomeNuVasive Inc.NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System...

NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening

NuVasive, Inc. today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™. The Precice system is an internal nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb.

“Precice has completely changed the game in limb lengthening and reconstruction surgery and is rapidly becoming the gold standard of care for patients with conditions related to limb-length discrepancy,” said Stuart Green, MD, orthopedic surgeon at UC Irvine School of Medicine. “Before Precice, patients were limited to bulky, painful external fixation devices that significantly impacted their mobility and comfort. We have seen a huge paradigm shift in the last few years with the adoption of Precice, due to the reliability of the External Remote Control, the precision of lengthening and compression, patient comfort, the dramatic reduction of infections and the elimination of disfiguring scars when compared with external skeletal fixators.”

The Precice system is a state-of-the-art device designed to eliminate the need for external fixation devices or shortening of the healthy limb, both of which were previously considered the gold standard of care for patients with a limb length discrepancy. An intramedullary nail is implanted into the patient’s femur, tibia or humerus, and is remotely controlled through a complex internal gear system. Physicians personalize treatment based on the individual needs of the patient by programming the ERC to perform customizable lengthening until prescribed correction is achieved. Once programmed, patients utilize the remote for just seven minutes per day, and can achieve up to 80mm of limb lengthening throughout the treatment from the comfort of their own home.

“With over 10,000 devices implanted and more than 30 peer-reviewed clinical studies published since its commercial release in 2011, Precice has proven to be a validated and preferred approach to addressing limb length discrepancies by surgeons and patients alike,” said Massimo Calafiore, president of NuVasive Specialized Orthopedics. “This milestone underscores NuVasive’s commitment to innovate with the mission of transforming the current standards of orthopedic care.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy